Shinnihonseiyaku Co., Ltd.
新日本製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4931
FY2024 · 2025-09-30
| Gross margin | 80.0% |
| Operating margin | 11.6% |
| Net margin | 6.2% |
| Return on equity | 11.4% |
| Return on assets | 9.0% |
| Revenue growth (YoY) | 2.7% |
| EPS (basic) | ¥120.48 |
| EPS growth (YoY) | -7.1% |
| Current ratio | 4.94x |
| Equity ratio | 79.4% |
| Book value / share | ¥1,078.69 |
| Free cash flow | 4,627 M |